AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC – Get Rating) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totalling 33,000 shares, a decrease of 97.9% from the March 15th total of 1,580,000 shares. Based on an average trading volume of 927,700 shares, the days-to-cover […]
AnPac Bio enters into $15 million financing deal - Philadelphia Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
09.04.2022 - PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) - AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and . Seite 1